China Periodontal Therapeutics Market Analysis

China Periodontal Therapeutics Market Executive Summary

China Periodontal Therapeutics Market is at around $70.2 Mn in 2023 and is projected to reach $125.8 Mn in 2030, exhibiting a CAGR of 8.7% during the forecast period.

Gum inflammation and infection are common symptoms of periodontal disease, also referred to as gum disease, which is a serious dental condition. The use of therapeutic, non-surgical, or surgical treatment techniques can help prevent periodontitis, a prevalent ailment frequently brought on by poor dental hygiene. Periodontal therapy, which is the exclusive use of antibiotics to treat periodontitis, is a relatively new yet effective therapeutic approach that is gaining popularity among patients and dental professionals. Periodontal therapy frequently uses antibiotics such as metronidazole, doxycycline, and amoxicillin. The use of mouthwashes and rinses containing antimicrobials such as hydrogen peroxide, chlorhexidine, and essential oils as adjuvant therapy can lessen plaque and gingival irritation.

The periodontal disease market in China is witnessing significant growth, driven by high prevalence rates among the population. Nearly 90% of adults suffer from some form of periodontal disease. Demographic factors such as an aging population and increasing urbanization contribute to this rise. Additionally, changing lifestyles and dietary habits are exacerbating oral health issues. Healthcare expenditure on dental treatments is increasing as awareness and access to healthcare services improve. Therefore, the market is driven by significant factors like Economic Growth and Rising Disposable Income, Technological Advancements, and Emphasis on Preventive Oral Care. However, Stringent Regulatory Requirements, Side Effects and Complications, and High Costs restrict the growth and potential of the market.

Envista Holding Corporation formed a strategic partnership with the Spanish Dental Service Organization- Vitaldent Group. This helps the company to become the preferred supplier of dental implants.

Market Dynamics

Market Growth Drivers

Economic Growth and Rising Disposable Income: Robust economic growth has led to increased disposable income and improved living standards. With higher disposable income, more people can afford dental care and are willing to spend on advanced periodontal treatments. For instance, a recent survey indicated that 35% of households in developed economies are now allocating a portion of their income to dental care, up from 50% a decade ago. This economic shift is boosting the market for periodontal therapeutics as individuals prioritize health and wellness.

Technological Advancements: Technological advancements in dentistry have significantly improved periodontal disease diagnosis, treatment, and management. Thanks to advancements in digital dentistry, including better imaging methods, periodontists can now produce precise three-dimensional (3D) models of their patients' mouths. These models simplify the design of procedures like dental implants, which enhances treatment precision and practitioner communication. As a result, patient outcomes improve and dental care becomes more effective and productive.

Emphasis on Preventive Oral Care: Taking care of your gums is more than just brushing and flossing. Dentists now focus on preventing gum problems before they start. They teach patients about oral health, offer special cleaning services, and create personalized care plans. Regular check-ups help catch issues early. Your dentist considers your unique risks and habits to make a plan that works for you. This approach helps keep your gums healthy and prevents bigger problems down the road. By working closely with your dentist, you can maintain a healthy smile for life.

Market Restraints

Stringent Regulatory Requirements: China's complex regulatory landscape includes strict registration requirements for dental products and treatments, leading to lengthy approval processes and market entry delays. Intellectual property protection challenges and local manufacturing requirements further complicate market access for international periodontal care providers.

Side Effects and Complications: Challenges for the periodontal market is the potential for adverse reactions to dental materials used in treatments, including allergies or sensitivities, which can lead to patient discomfort and dissatisfaction. Additionally, the perception of pain or discomfort associated with periodontal surgeries may deter individuals from seeking timely and comprehensive oral care.

High cost: The disparity between urban and rural healthcare services means that advanced dental care is often prohibitively expensive for a large portion of the population. The high cost of imported dental materials and advanced technologies further drives up treatment prices. For instance, in rural areas, dental treatments can cost up to 30% more due to these factors. Additionally, the limited coverage of dental procedures under public health insurance schemes leaves many individuals to bear significant out-of-pocket expenses. These financial constraints hinder the accessibility and growth of the periodontal market in China, affecting overall oral health outcomes.

Regulatory Landscape and Reimbursement scenario

China's periodontics market is influenced by a complex regulatory landscape. The National Health Commission (NHC) oversees dental care standards, including periodontics. The National Medical Products Administration (NMPA) regulates dental devices and materials. Recent reforms focus on improving dental care access, enhancing practitioner qualifications, and encouraging innovation in dental technologies. The Healthy China 2030 plan emphasizes preventive care, which boosts the periodontics sector. However, regulatory challenges include navigating bureaucratic processes and ensuring compliance with stringent standards. The market is poised for growth, driven by increasing health awareness and government support for healthcare modernization.

Periodontal market faces challenges due to the limited reimbursement policies for dental care. Currently, dental treatments, including periodontal procedures, are not comprehensively covered by the national health insurance system. Patients often bear out-of-pocket expenses, which can be substantial. This financial burden discourages many from seeking necessary periodontal care, leading to a gap in preventative and therapeutic dental services. Efforts are ongoing to improve insurance coverage and reduce costs, but significant progress is still needed to make periodontal treatments more accessible and affordable for the broader population. This scenario highlights the need for policy reform to enhance oral health outcomes in China.

Competitive Landscape

Key Players

Here are some of the major key players in China Periodontal Therapeutics Market:

• Chartwell Pharmaceuticals LLC.
• ASA Dental S.p.A.
• Steris-Hu-Friedy
• Envista Holding Corporation
• Tokyo Chemical Industry Co., Ltd.
• Bausch Health Companies Inc.
• Melinta Therapeutics LLC
• Pfizer Inc.
• Lupin Ltd
• Teva Pharmaceuticals USA, Inc.
• Sun Pharmaceutical Industries Ltd.
• Cipla, Inc.
• Carl Martin GmBH